ey0015.9-3 | Late consequences of tumour therapy: prevention and monitoring | ESPEYB15
S Elitzur
, R Houri-Shtrecher
, M Yackobovitz-Gavan
, G Avrahami
, S Barzilai
, G Gilad
, Y Lebenthal
, M Phillip
, B Stark
, I Yaniv
, S Shalitin
To read the full abstract: J Pediatr Endocrinol Metab. 2017;30:869-877Several previous studies had focused on the early risk of metabolic syndrome or its components in survivors of childhood acute lymphoblastic leukaemia (ALL), while fewer data are available on pubertal development in these subjects. The merit of this study was to carefully investigate growth and pubertal development in a large ...